In patients with high-risk HER2-positive breast cancer, post-surgery, or adjuvant, treatment with trastuzumab emtansine (T-DM1) reduced the long-term risk of death or invasive disease by 46% and ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

Many young women gain weight in the years after breast reduction surgery, according to a study published online in the ...

Many women may opt for a breast reduction if they encounter issues such as recurrent neck, back and shoulder pain. However, a ...

In the ALEXANDRA/IMpassion030 trial, Tecentriq (atezolizumab) added to postoperative chemotherapy was not found to improve treatment outcomes for patients with high-risk early-stage triple-negative ...

The NBC 6 News Team presents a morning newscast featuring local and national events, along with weather and traffic updates ...